ImmunityBio, Inc. (IBRX) has 4 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $1.6M. Most recent filing: July 6, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 6, 2026 filed July 2, 2026 | Cohen Cheryl Director | −$714,950 | 243,168 | −40% | Yes | |
|
|
||||||
| July 6, 2026 filed July 1, 2026 | Selecky Christobel Director | $963,821 | 478,434 | — | Yes | |
|
|
||||||
| July 1, 2026 filed June 29, 2026 | Selecky Christobel Director | — | 0 | 0% | Yes | |
|
|
||||||
| June 26, 2026 filed June 24, 2026 | Simon Barry J. Director | −$196,908 | 25,000 | −1% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free